Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001440895 | SCV001643812 | likely benign | Wolman disease | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002405036 | SCV002670519 | likely benign | Cardiovascular phenotype | 2021-04-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001826258 | SCV002091510 | likely benign | Lysosomal acid lipase deficiency | 2021-09-24 | no assertion criteria provided | clinical testing |